NOVAVAX ($NVAX) posted quarterly earnings results for Q4 2025 on Thursday, February 26th. The company reported earnings of $0.11 per share, beating estimates of -$0.50 by $0.61. The company also reported revenue of $147,140,000, beating estimates of $80,881,338 by $66,258,662.
You can see Quiver Quantitative's $NVAX stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
NOVAVAX Hedge Fund Activity
We have seen 103 institutional investors add shares of NOVAVAX stock to their portfolio, and 160 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BANK OF AMERICA CORP /DE/ added 5,189,591 shares (+167.3%) to their portfolio in Q4 2025, for an estimated $34,874,051
- COATUE MANAGEMENT LLC removed 3,836,986 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $25,784,545
- SHAH CAPITAL MANAGEMENT added 2,747,000 shares (+23.3%) to their portfolio in Q4 2025, for an estimated $18,459,840
- MORGAN STANLEY added 2,641,540 shares (+245.4%) to their portfolio in Q4 2025, for an estimated $17,751,148
- MILLENNIUM MANAGEMENT LLC added 2,342,804 shares (+110.1%) to their portfolio in Q4 2025, for an estimated $15,743,642
- STATE STREET CORP added 2,326,927 shares (+32.3%) to their portfolio in Q4 2025, for an estimated $15,636,949
- D. E. SHAW & CO., INC. added 1,718,719 shares (+40.2%) to their portfolio in Q4 2025, for an estimated $11,549,791
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
NOVAVAX Analyst Ratings
Wall Street analysts have issued reports on $NVAX in the last several months. We have seen 3 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- BTIG issued a "Buy" rating on 01/20/2026
- JP Morgan issued a "Underweight" rating on 11/18/2025
- B. Riley Securities issued a "Buy" rating on 11/10/2025
- Cantor Fitzgerald issued a "Overweight" rating on 10/24/2025
To track analyst ratings and price targets for NOVAVAX, check out Quiver Quantitative's $NVAX forecast page.
NOVAVAX Price Targets
Multiple analysts have issued price targets for $NVAX recently. We have seen 6 analysts offer price targets for $NVAX in the last 6 months, with a median target of $13.5.
Here are some recent targets:
- Thomas Shrader from BTIG set a target price of $19.0 on 01/20/2026
- Anupam Rama from JP Morgan set a target price of $6.0 on 11/18/2025
- Mayank Mamtani from B. Riley Securities set a target price of $16.0 on 11/10/2025
- Brendan Smith from TD Cowen set a target price of $7.0 on 11/04/2025
- Pete Stavropoulos from Cantor Fitzgerald set a target price of $18.0 on 10/24/2025
- Sean Lee from HC Wainwright & Co. set a target price of $11.0 on 10/23/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
